Rachor Investment Advisory Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$101K Buy
4,212
+108
+3% +$2.83K 0.05% 44
2026
Q1
$115K Buy
4,104
+65
+2% +$1.73K 0.06% 34
2025
Q4
$101K Buy
+4,039
New +$102K 0.05% 38

Other funds holding PFE

Rachor Investment Advisory Services's PFE Position: Q2 2026 in Review

Rachor Investment Advisory Services increased its Pfizer (PFE) stake by 2.6% in Q2 2026, buying an estimated $2.83K and bringing the position to 4,212 shares worth $101K. The position accounts for 0.05% of the portfolio, ranked #44.

Rachor Investment Advisory Services first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $115K in Q1 2026. 1,694 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Rachor Investment Advisory Services held 4,212 shares of Pfizer worth $101K as of Q2 2026.
  • Rachor Investment Advisory Services bought 108 Pfizer shares in Q2 2026, an estimated $2.83K.
  • Pfizer made up 0.05% of Rachor Investment Advisory Services's portfolio in Q2 2026, its #44 holding.
  • Rachor Investment Advisory Services first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • Rachor Investment Advisory Services's Pfizer position peaked at $115K in Q1 2026.
  • 1,694 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Rachor Investment Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.